Stock listing
Pharmalundensis Ab
Selected listing: PHAL · NGM · SEK · SE
Pharmalundensis Ab (NGM:PHAL), Health Technology. Latest release May 28, 2026: PHAL: Net loss widened to -1.56 million SEK; delisting and international…
- Ticker
- NGM:PHAL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NGM
- Currency
- SEK
About Pharmalundensis Ab
Pharmalundensis Ab is a public company listed on the Swedish market under the ticker PHAL. Pharmalundensis focuses on the development and commercialization of innovative pharmaceutical solutions.
Latest news from Pharmalundensis Ab
PHAL: Net loss widened to -1.56 million SEK; delisting and international financing initiatives underway
May 28, 2026
PHAL: Net loss deepened in 2025 as focus shifts to international funding and clinical trial execution
February 5, 2026
PHAL: Net loss increased, but strong market interest in Minievaporator offers future upside
November 20, 2025
PHAL: Losses increased as net sales stayed at zero; new capital extends operations but debt remains
August 21, 2025
PHAL: Net loss persists, but R&D and cleantech advances drive optimism amid tight liquidity
May 15, 2025